What Happened?
Shares of health insurance company UnitedHealth (NYSE: UNH) fell 22.9% in the morning session after the company reported underwhelming first-quarter 2025 results as its sales and profits fell below Wall Street expectations.
The real story was the sudden rise in health care activity among seniors in its Medicare plans, which pushed costs higher and hurt profits. Some of those activities were delayed visits dating back to the COVID period. As a result, while revenue grew 10% from the previous year, costs grew faster. This reflected in the medical care ratio, which ticked up, meaning more of each dollar went to covering claims, and the company expected the ratio to increase significantly in the near term.
Guidance was the biggest concern. The new full-year earnings forecast came in well below what analysts had been expecting, mainly because the company saw its care (medical costs in its privately run Medicare plans) and funding issues lasting longer.
Overall, this was a disappointing quarter. While top-line growth was decent, bottom-line pressures and reimbursement risk remain unresolved, clouding the earnings outlook.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy UnitedHealth? Access our full analysis report here, it’s free.
What The Market Is Telling Us
UnitedHealth’s shares are not very volatile and have only had 9 moves greater than 5% over the last year. Moves this big are rare for UnitedHealth and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was about 2 months ago when the stock dropped 12.5% on the news that The Wall Street Journal reported that the Department of Justice was investigating the company regarding concerns linked to its Medicare billing practices.
UnitedHealth is down 10% since the beginning of the year, and at $453.74 per share, it is trading 27.4% below its 52-week high of $625.25 from November 2024. Investors who bought $1,000 worth of UnitedHealth’s shares 5 years ago would now be looking at an investment worth $1,562.
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. We prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
